Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors
Open Access
- 10 April 2025
- journal article
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 43, 51-58
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21Journal of Antimicrobial Chemotherapy, 2024
- Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of Human Immunodeficiency Virus 1 Subtype A6The Journal of Infectious Diseases, 2023
- Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic FailureClinical Infectious Diseases, 2023
- Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean EuropeClinical Infectious Diseases, 2022
- Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014–2018Clinical Infectious Diseases, 2021
- Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UKJournal of Antimicrobial Chemotherapy, 2020
- Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimenInternational Journal of Antimicrobial Agents, 2020
- Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical ImpactThe Journal of Infectious Diseases, 2019
- Impact of transmitted HIV-1 drug resistance on the efficacy of first-line antiretroviral therapy with two nucleos(t)ide reverse transcriptase inhibitors plus an integrase inhibitor or a protease inhibitorJournal of Antimicrobial Chemotherapy, 2018
- The Role of HIV-1 Drug-Resistant Minority Variants in Treatment FailureThe Journal of Infectious Diseases, 2017